Nadim Ahmed Net Worth & Insider Trades

Nadim Ahmed - President and CEO, Cullinan Oncology, Inc

As of July 5, 2022

What is Nadim Ahmed's Net Worth?

The current estimated net worth of Cullinan Oncology, Inc's President and CEO, Nadim Ahmed, is estimated to be about $2.9M . Nadim Ahmed owns about 8,090 units of Cullinan Oncology, Inc common stock. In the last year at Cullinan Oncology, Inc, Nadim Ahmed has sold an estimated value of $0 worth.

What is Nadim Ahmed's Past Insider Trading?

Nadim Ahmed's largest purchase order was 8,090 units , worth over $100.32K on June 7, 2022. In total, Nadim Ahmed has made about 4 transactions over a year of their time at Cullinan Oncology, Inc. Nadim Ahmed usually trades in July, June, October and March, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Nadim Ahmed's' Mailing Address?

  • Mailing address is C/o Celgene Corporation 86 Morris Avenue Summit NJ 07901 NJ

Cullinan Oncology, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Owen Hughes 2020 $461,250 $245,063 $530,320 $5,301,175 $14,250 $6,552,058
Owen Hughes 2019 $450,000 $96,800 - - $14,000 $560,800
Patrick Bauerle, Ph.D. 2020 $436,997 $266,131 $491,284 $4,124,284 $34,800 $5,353,497
Patrick Bauerle, Ph.D. 2019 $420,895 $107,502 - - $34,400 $562,797
Jon Wigginton, M.D. 2020 $321,122 $258,000 - $3,959,525 $5,375 $4,544,022
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1789972/000119312521140630/d170327ddef14a.htm

What are Cullinan Oncology, Inc's Past Insider Trades?

Cullinan Oncology, Inc's most recent insider trade came on August 9, 2022 by Jennifer Michaelson who sold 1,385 units worth $20.79K . In the last year, insiders at Cullinan Oncology, Inc have sold an estimated value of $28.88M and bought an estimated value of $39.24M worth of shares. Insider trading is most common in September, with the busiest year in 2021. The most active traders at the company are Ansbert Gadicke, Director,  Bioimpact Capital Llc,  and Oncology Impact Fund Cayman Management Lp .

Cullinan Oncology, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1